These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20411765)

  • 21. Phasic activation of substantia nigra and the ventral tegmental area by chemical stimulation of the superior colliculus: an electrophysiological investigation in the rat.
    Coizet V; Comoli E; Westby GW; Redgrave P
    Eur J Neurosci; 2003 Jan; 17(1):28-40. PubMed ID: 12534966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration.
    Frank-Cannon TC; Tran T; Ruhn KA; Martinez TN; Hong J; Marvin M; Hartley M; Treviño I; O'Brien DE; Casey B; Goldberg MS; Tansey MG
    J Neurosci; 2008 Oct; 28(43):10825-34. PubMed ID: 18945890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M; Romero-Ramos M; Carta M; Kirik D
    Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
    Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
    Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
    Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
    Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related gene expression changes in substantia nigra dopamine neurons of the rat.
    Parkinson GM; Dayas CV; Smith DW
    Mech Ageing Dev; 2015 Jul; 149():41-9. PubMed ID: 26065381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oscillatory firing of dopamine neurons: differences between cells in the substantia nigra and ventral tegmental area.
    Zhang D; Yang S; Jin GZ; Bunney BS; Shi WX
    Synapse; 2008 Mar; 62(3):169-75. PubMed ID: 18081182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease?
    von Linstow CU; DeLano-Taylor M; Kordower JH; Brundin P
    J Parkinsons Dis; 2020; 10(2):405-411. PubMed ID: 31958098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.
    Thompson L; Barraud P; Andersson E; Kirik D; Björklund A
    J Neurosci; 2005 Jul; 25(27):6467-77. PubMed ID: 16000637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
    Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
    Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.
    Brichta L; Greengard P
    Front Neuroanat; 2014; 8():152. PubMed ID: 25565977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice.
    Albright JE; Stojkovska I; Rahman AA; Brown CJ; Morrison BE
    Neurosci Lett; 2016 Feb; 615():50-4. PubMed ID: 26806039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration.
    Fu Y; Paxinos G; Watson C; Halliday GM
    J Chem Neuroanat; 2016 Oct; 76(Pt B):98-107. PubMed ID: 26859066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
    Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
    J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic neurons.
    Chinta SJ; Andersen JK
    Int J Biochem Cell Biol; 2005 May; 37(5):942-6. PubMed ID: 15743669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.